ArticleCost effectiveness and resource allocation : C/E2013
Calculating disability-adjusted-life-years lost (DALYs) in discrete-time.
Article in Cost effectiveness and resource allocation : C/E, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.BMC public health · 2023Pooled it
- The cost-effectiveness of community health workers delivering free diarrhoea treatment: evidence from Uganda.Health policy and planning · 2022Trial
- Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania.BMC medicine · 2026Article
- Early versus delayed enteral nutrition in critically ill children under 12 years of age: an economic evaluation.Cost effectiveness and resource allocation : C/E · 2025Article
- Sub-national landscape on the years of life lost due to COVID-19 pandemic in the major cities of Southern Philippines.Journal of public health (Oxford, England) · 2025Article
- Modeling Disability-Adjusted Life-Years for Policy and Decision Analysis.Medical decision making : an international journal of the Society for Medical Decision Making · 2025Article
- Innovative timing strategies for tuberculosis household contact investigation: cost-effectiveness analysis from a randomized trial in rural and urban South Africa (Kharituwe Study).EClinicalMedicine · 2025Article
- Cost-effectiveness of oil and milk fortification by scale for reducing Vitamin A and Vitamin D deficiency in India.PloS one · 2025Article
- Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa.Cancer medicine · 2023Article
- Assessing the Environmental-Health-Economic Co-Benefits from Solar Electricity and Thermal Heating in Ulaanbaatar, Mongolia.International journal of environmental research and public health · 2022Article
- Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals.JCO global oncology · 2021Article
- Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.Malaria journal · 2021Article
- Association of a Network of Immunologic Response and Clinical Features With the Functional Recovery From Crotalinae Snakebite Envenoming.Frontiers in immunology · 2021Article
- Article
- Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study.JMIR research protocols · 2020Article
- Article
- Cost-effectiveness of community-based screening and treatment of moderate acute malnutrition in Mali.BMJ global health · 2019Article
- Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004-2014).Infectious diseases of poverty · 2017Article
- The socio-economic burden of snakebite in Sri Lanka.PLoS neglected tropical diseases · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disability-adjusted-life-years lost (DALYs) is a common outcome metric for cost-effectiveness analyses, and the equations used for such calculations have been presented previously by Fox-Rushby and Hanson (see, e.g., "Health Policy and Planning 16:326-331, 2001"). While the equations are clear, the logic behind them is opaque at best for a large share of public health practitioners and students. The objective of this paper is to show how to calculate DALYs using a discrete time formulation that is easy to teach to students and public health practitioners, is easy to apply for those with basic discounting skills, and is consistent with the discounting methods typically included on the costing side of cost-effectiveness analysis. A continuous-time adjustment factor is derived that can be used to ensure exact consistency between the continuous and discrete time approaches, but this level of precision is typically unnecessary for cost-effectiveness analyses. To illustrate the approach, both a new, simple example and the same example presented in Fox-Rushby and Hanson are used throughout the paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.